National Institute of Allergy and Infectious Diseases (NIAID)
Why trials sponsored by National Institute of Allergy and Infectious Diseases (NIAID) stopped, in this sample of ClinicalTrials.gov.
24 stopped trials with a clear reason; 88% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| slow accrual | 13 | 54% |
| funding business | 4 | 17% |
| futility | 2 | 8% |
| manufacturing supply | 2 | 8% |
| safety | 1 | 4% |
| regulatory | 1 | 4% |
| logistics pi | 1 | 4% |
Trials
- Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)
NCT05652504 · WITHDRAWN · funding business
“Sponsor discontinued development of the investigational vaccine for this protocol and shifted to an alternative investigational product.” - Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
NCT06705478 · SUSPENDED · slow accrual
“Temporarily Closed (Paused) to Accrual” - A Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV
NCT06905275 · SUSPENDED · slow accrual
“Temporarily Closed (Paused) to Accrual” - Skin Immunity Sample Collection Involving Blisters and Biopsies
NCT03921515 · WITHDRAWN · slow accrual
“Study closed by PI, no enrollment.” - Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA
NCT05710640 · TERMINATED · funding business
“Study was terminated due to feasibility concerns and budget constraints.” - A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults
NCT05470400 · TERMINATED · regulatory
“The HVTN 303 IND was placed on clinical hold, and recruitment did not resume.” - A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.
NCT04840199 · TERMINATED · slow accrual
“Permanently closed to screening and accrual due to futility” - Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
NCT04518228 · TERMINATED · slow accrual
“The study was closed to accrual early based on Study Monitoring Committee review indicating that the study objectives had either been achieved or could not be met within a reasonable timeframe for the then-open arms.” - Liver Transplantation With Tregs at UCSF
NCT03654040 · TERMINATED · funding business
“The study was terminated by the Sponsor prior to any participants receiving the investigational product.” - Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
NCT02644525 · TERMINATED · futility
“Planned interim analysis demonstrated futility of intervention” - A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area
NCT03548064 · TERMINATED · logistics pi
“COVID 19 cases at the site” - Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults
NCT03505060 · WITHDRAWN · manufacturing supply
“One of the study products is no longer available for clinical trial use.” - Safety and Efficacy Study of Oral Fosfomycin Versus Oral Levofloxacin to Treat Complicated Urinary Syndromes (FOCUS)
NCT03697993 · TERMINATED · slow accrual
“inadequate enrollment.” - A Single Dose of Pembrolizumab in HIV-Infected People
NCT03367754 · TERMINATED · slow accrual
“Difficulty with subject recruitment” - Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age
NCT02890381 · TERMINATED · futility
“Interim data indicated this vaccine will not meet the protocol criteria for a good vaccine candidate.” - BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
NCT02029638 · TERMINATED · slow accrual
“Slow accrual” - Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
NCT01946880 · TERMINATED · slow accrual
“Slow enrollment.” - Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
NCT01769443 · TERMINATED · slow accrual
“Inability to enroll within funding period” - Inducing Remission in Type 1 Diabetes With Alefacept
NCT00965458 · TERMINATED · funding business
“Manufacturer discontinued production of Amevive®: business decision.” - A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
NCT00913692 · TERMINATED · slow accrual
“Terminated due to slow recruitment.” - Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
NCT00527878 · TERMINATED · slow accrual
“Failure to enroll adequate patient numbers due to small number of eligible patients” - Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
NCT00034528 · TERMINATED · slow accrual
“Due to slow recruitment” - Steroid Withdrawal in Pediatric Kidney Transplant Recipients
NCT00023244 · TERMINATED · safety
“Effective August 13, 2004: Unanticipated high incidence of post-transplant lymphoproliferative disorder” - SCH708980 With and Without AmBisome for Visceral Leishmaniasis
NCT01437020 · WITHDRAWN · manufacturing supply
“Drug Product no longer available.”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.